Susquehanna International Group, LLP Biocept Inc Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 16, 2023	BUY	$0.24 - $0.62 $2,479 - $6,405	10,331 Added 85.06%	22,477 $7,000
Q4 2022 Feb 14, 2023	SELL	$0.47 - $0.89 $3,557 - $6,736	-7,569 Reduced 38.39%	12,146 $6,000
Q3 2022 Nov 14, 2022	BUY	$0.75 - $1.2 $14,786 - $23,658	19,715 New	19,715 $18,000
Q4 2021 Feb 14, 2022	BUY	$3.43 - $4.22 $43,300 - $53,273	12,624 Added 79.38%	28,528 $103,000
Q3 2021 Nov 15, 2021	BUY	$3.39 - $4.34 $18,631 - $23,852	5,496 Added 52.81%	15,904 $64,000
Q2 2021 Aug 11, 2021	SELL	$4.03 - $5.07 $240,091 - $302,050	-59,576 Reduced 85.13%	10,408 $44,000
Q1 2021 May 17, 2021	BUY	$4.74 - $7.94 $331,724 - $555,672	69,984 New	69,984 $356,000

Ticker BIOC
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,922,900
Market Cap $1.18M
Description
Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.